ACXP Earnings

Quarterly EPS
$-3.45
Q3 2024
$-1.17
Q4 2024
$-2.15
Q1 2025
$-1.89
Q2 2025
$-1.23
Q3 2025
$-0.72
Q4 2025
$-0.62
Q1 2026
$-0.53
Q2 2026
Latest RevenueN/A
Latest Net Income-2254173
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.530-2254173+72.0%
Q1 2026-$0.620-1680982+71.2%
Q4 2025-$0.720-1578276+38.5%
Q3 2025-$1.230-1992790+64.3%
Q2 2025-$1.890-2246279+63.7%
Q1 2025-$2.150-2149193+61.6%
Q4 2024-$1.170-2781791+84.1%
Q3 2024-$3.450-2821597+28.1%
Q2 2024-$5.210-4121826
Q1 2024-$5.600-4377889
Q4 2023-$7.380-5114590
Q3 2023-$4.800-3114981
Acurx Pharmaceuticals (ACXP) — Earnings